The EMA and FDA have published a set of 10 'common principles' that should be taken into account when using AI in the development of medicines. The list has emerged as the adoption of AI among ...
The FDA announced it planned to restrict use of GLP-1 active pharmaceutical ingredients in non-FDA-approved drugs, including those from Hims & Hers and other compounding pharmacies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results